Clinical Trial Update: Effect of Galantamine on Inflammation and Cognition [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating galantamine for inflammation and cognitive outcomes in HIV-associated cognitive motor complex has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hiv-associated Cognitive Motor Complex

Drugs mentioned

• Galantamine (galantamine)

Snippet

Sponsor: University of Pennsylvania | Conditions: HIV Associated Cognitive Motor Complex | Phase 2 | Status: COMPLETED | Results posted: 2024-10-17